SB
ALPN

Samsara BioCapital’s Alpine Immune Sciences Inc ALPN Stock Holding History

Samsara BioCapital’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-275,169
Closed -$2.48M – 49
2021
Q2 		$2.48M Sell
275,169
-124,021
-31% -$1.35M 0.31% 40
2021
Q1 		$4.23M Hold
399,190
– – 0.78% 30
2020
Q4 		$5.03K Sell
399,190
-95,000
-19% -$932K 0.51% 22
2020
Q3 		$4.34M Buy
+494,190
New +$4.52M 1.21% 20

Other funds holding ALPN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Samsara BioCapital's ALPN Position: Q3 2021 in Review

Samsara BioCapital sold out of Alpine Immune Sciences Inc (ALPN) in Q3 2021, closing a stake of 275,169 shares — an estimated $2.48M sold.

Samsara BioCapital first reported a position in ALPN in Q3 2020 and held it in 4 quarters. The position peaked at $4.34M in Q3 2020. 44 funds tracked by Wall St. Rank hold ALPN as of Q3 2021.

  • Samsara BioCapital reported no remaining Alpine Immune Sciences Inc position as of Q3 2021 after selling out during the quarter.
  • Samsara BioCapital sold 275,169 Alpine Immune Sciences Inc shares in Q3 2021, an estimated $2.48M.
  • Samsara BioCapital first reported a position in Alpine Immune Sciences Inc in Q3 2020 and held it in 4 quarters.
  • Samsara BioCapital's Alpine Immune Sciences Inc position peaked at $4.34M in Q3 2020.
  • 44 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q3 2021.

Based on Samsara BioCapital's 13F filing for Q3 2021, filed 15 Nov 2021.